PHARMACOGENETICS OF OPIOID SUBSTITUTION TREATMENT RESPONSE (POST) STUDY
BRAVE for Bipolar
Behavioural activation (BA) is a form of therapy that has shown promise in depression, and may also have benefits in treatment of bipolar disorder. The BRAVE program uses BA components, such as activity tracking and skill building to help reduce symptoms experienced in bipolar disorder, including symptoms of depression. The BRAVE project aims to investigate whether this form of treatment is helpful for people with bipolar disorder.
Who can participate in this study?
You are able to participate in this study if you:
Are 18 years of age or older
Have bipolar disorder
Can attend virtual group sessions twice weekly and complete electronic questionnaires that help us understand if this program is working for you.
Why should I participate in this study?
The information and results of this study will establish if this is a program that is helpful for bipolar patients. If found to be helpful, this will provide more treatment options for these patients. By participating in this study, you will have access to the BRAVE program, which will expose you to skills and techniques that have been found to be helpful in depression.
How long is this study?
The BRAVE program is 14 weeks long, with 8 weeks of virtual group sessions (twice per week) and two individual sessions over the final 6 weeks.
You may be assigned to the intervention group (BRAVE Program) or to the waitlist. If you are assigned to the intervention, you will start BA as soon as the next set of group sessions begin. If you are assigned to the waitlist, you will wait for approximately 14 weeks and then start the next set of group sessions.
I think I want to participate, what would I need to do if I choose to be a part of the study?
First, you can let us know you are interested in our study, and we will ask a few questions to make sure you are eligible to participate (you can find the link our email at the bottom of this page).
Next, if you are eligible to participate, you will be contacted by a research assistant over the phone for a baseline study visit. You can ask questions about the study, and if you are comfortable, you will provide consent to participate. During this visit will be virtual, and you will be asked questions about your health, socio-demographic information, treatment received and psychological wellbeing.
We will ask for a blood sample a few times during the study to help us determine if genetics have a role in treatment of bipolar disorder. Due to COVID-19, this part of the study has been put on hold in order to follow physical distancing measures.
Once you have completed the baseline visit, you will contacted about which group you have been placed in. In both groups, you will be asked to provide us with information about how you are doing by completing electronic questionnaires.
Are you interested and think you may be eligible to participate in this study?
To get in touch with a research assistant to learn more about your possible participation, please click the link below, or call: 905-522-1155 ext. 39065.
Please indicate the study you are interested in, and a member of our research team will help determine if the study is right for you!